Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery

Chest

Volumn 116, Issue 5, 1999, Pages 1240-1246

  Douketis, James D ^a,b   Crowther, Mark A ^a,b   Cherian, Sunjay S ^a   Kearon, Clive B ^a,c  

^a Department of Medicine ^*  (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulation; Embolism; Mechanical heart valve; Surgery; Thrombosis

Indexed keywords

HEPARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; ELECTIVE SURGERY; HEART VALVE PROSTHESIS; HUMAN; PHYSICIAN ATTITUDE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0032718911     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1240     Document Type: Article

References (28)

1. 1 Stein PD, Alpert JS, Dalen JE, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998; 114(suppl 5):602S-610S
2. 2 Silber H, Kahn SS, Matloff JM, et al. The St. Jude valve: thrombolysis as the first level of therapy for cardiac valve thrombosis. Circulation 1993; 87:30-37
3. 3 Edmunds LH Jr. Thromboembolic complications of current cardiac valve prostheses. Ann Thorac Surg 1982; 34:96-106
4. 4 Levine M, Raskob GE, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 1998; 114(suppl 5):511S-523S
5. 5 Vongpatanasin W, Hillis D, Lange RA. Prosthetic heart valves. N Engl J Med 1996; 335:407-416
6. 6 Bryan AJ, Butchart EG. Prosthetic heart valves and anticoagulant management during non-cardiac surgery. Br J Surg 1995; 82:577-578
7. 7 Travis S, Wray R, Harrison K. Perioperative anticoagulation control. Br J Surg 1989; 76:1107-1108
8. 8 Madura JA, Rookstool M, Wease G. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures. Am Surgeon 1994; 60:542-547
9. 9 Busuttil WJ, Fabri BM. The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations. Postgrad Med J 1995; 71:390-392
10. 10 Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of prosthetic valve anticoagulation. Mayo Clin Proc 1998; 73:665-680
11. 11 Blaustein AS. Preoperative and perioperative management of cardiac patients undergoing noncardiac surgery. Cardiol Clin 1995; 13:149-160
12. 12 Kuwada SK, Balm R, Gostout CJ. The risk of withdrawing chronic anticoagulation because of acute GI bleeding. Am J Gastroenterol 1996; 91:1116-1119
13. 13 Tinker JH, Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. JAMA 1978; 239:738-739
14. 14 Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336:1506-1511
15. 15 Eckman MH, Beshansky JR, Durand-Zaleski I, et al. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. JAMA 1990; 263:1513-1521
16. 16 Katholi RE, Nolan SP, McGuire LB. Living with prosthetic heart valves: subsequent noncardiac operations and the risk of thromboemholism of hemorrhage. Am Heart J 1976; 92:162-167
17. 17 Shean FC, Austen WG, Buckley MJ, et al. Survival after Starr-Edwards aortic valve replacement. Circulation 1971; 41:1-8
18. 18 Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. Am Heart J 1978; 96:163-165
19. 19 Low-molecular-weight heparin is an effective and safe treatment for deep vein thrombosis and pulmonary embolism: The Columbus Investigators. N Engl J Med 1997; 337:657-662
20. 20 Hommes DW, Bura A, Mazzolai L, et al. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. Ann Intern Med 1992; 116:279-284
21. 21 Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997; 337:447-452
22. 22 McIntyre K. Medicolegal implications of consensus statements with special attention to the Fifth Antithrombotic Therapy Consensus Conference. Chest 1998; 114(suppl 5): 742S-747S
23. 23 Darmon D, Enriquez-Sarano M, Acar J. Cardiac complications after subsequent non-cardiac operations in patients with non-biological prosthetic heart valves [abstract]. Eur J Cardiol 1983; 4(suppl 1):30
24. 24 Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89:635-641
25. 25 Bigg SW, Catalona WJ. Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy: a prospective trial. Urology 1992; 39:309-313
26. 26 Turpie AGG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients: a randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression. Arch Intern Med 1989; 149:679-681
27. 27 Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991; 151:1950-1953
28. 28 Chang HJ, Bell JR, Deroo DB, et al. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990; 150:81-84